Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug targets
Biotech
Merck hands over $20M in IBD target deal with Quotient
After generating interest from Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.
Fraiser Kansteiner
Mar 24, 2026 6:00am
VantAI plays matchmaker for Halda's RIPTACs in $1B deal
Aug 19, 2025 8:00am
Biotech founder debuts tool to find microprotein drug targets
Aug 11, 2025 7:00am
Scientists ID target to prevent cancer from spreading to bones
May 21, 2025 2:00pm
Mitochondrial free radicals spur micronuclear collapse in cancer
Aug 29, 2024 2:00pm
Boehringer bets $509M on Phenomic's AI tech to reach tumors
Nov 29, 2023 8:00am
